GTAM
ALNY icon

Global Trust Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Global Trust Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Sell
59
-1
-2% -$302 0.01% 310
2026
Q1 		$19.9K Hold
60
– – 0.01% 318
2025
Q4 		$23.9K Hold
60
– – 0.01% 286
2025
Q3 		$27.4K Hold
60
– – 0.01% 318
2025
Q2 		$19.6K Sell
60
-62
-51% -$17.2K 0.01% 335
2025
Q1 		$32.9K Hold
122
– – 0.02% 275
2024
Q4 		$28.7K Hold
122
– – 0.01% 330
2024
Q3 		$33.6K Hold
122
– – 0.01% 309
2024
Q2 		$29.6K Hold
122
– – 0.01% 294
2024
Q1 		$18.2K Hold
122
– – 0.01% 324
2023
Q4 		$23.4K Hold
122
– – 0.01% 291
2023
Q3 		$21.6K Hold
122
– – 0.01% 289
2023
Q2 		$23.2K Hold
122
– – 0.01% 285
2023
Q1 		$24.4K Hold
122
– – 0.01% 266
2022
Q4 		$29K Hold
122
– – 0.01% 248
2022
Q3 		$24K Hold
122
– – 0.01% 263
2022
Q2 		$18K Hold
122
– – 0.01% 287
2022
Q1 		$20K Hold
122
– – 0.01% 332
2021
Q4 		$21K Sell
122
-13
-10% -$2.42K 0.01% 311
2021
Q3 		$25K Hold
135
– – 0.01% 277
2021
Q2 		$23K Hold
135
– – 0.01% 285
2021
Q1 		$19K Buy
+135
New +$20.3K 0.01% 262

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Trust Asset Management's ALNY Position: Q2 2026 in Review

Global Trust Asset Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 1.7% in Q2 2026, selling an estimated $302 and leaving 59 shares worth $17.8K. The position accounts for 0.01% of the portfolio, ranked #310.

Global Trust Asset Management first reported a position in ALNY in Q1 2021 and has held it in 22 quarters since. The position peaked at $33.6K in Q3 2024. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Global Trust Asset Management held 59 shares of Alnylam Pharmaceuticals worth $17.8K as of Q2 2026.
  • Global Trust Asset Management sold 1 Alnylam Pharmaceuticals share in Q2 2026, an estimated $302.
  • Alnylam Pharmaceuticals made up 0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #310 holding.
  • Global Trust Asset Management first reported a position in Alnylam Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Global Trust Asset Management's Alnylam Pharmaceuticals position peaked at $33.6K in Q3 2024.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.